Skip to main content
Fig. 3 | BMC Medical Imaging

Fig. 3

From: FDG PET using SUVmax for preoperative T-staging of esophageal squamous cell carcinoma with and without neoadjuvant chemoradiotherapy

Fig. 3

FDG PET (a–d) and corresponding fused PET/CT (e–h) transaxial images of four representative patients in the CRT[−] group. Increased FDG uptake ranged from mild to intense in the pathologically proven T1 tumor with SUVmax = 3.5 (a, e); T2 tumor with SUVmax = 5.8 (b, f); T3 tumor with SUVmax = 8.2 (c, g); T4 tumor with SUVmax = 13.7 (d, h). The reference ranges of SUVmax cut-offs selected for CRT[−] group were T1: 2.0–4.4, T2: 4.5–6.5, T3: 6.6–13.0, T4: >13.0

Back to article page

BMC Medical Imaging

ISSN: 1471-2342

Contact us